Protagonist Therapeutics
PTGX
#3077
Rank
A$7.41 B
Marketcap
A$118.65
Share price
-0.82%
Change (1 day)
97.36%
Change (1 year)

Market capitalization of Protagonist Therapeutics (PTGX)

Market cap: A$7.41 Billion

As of February 2026 Protagonist Therapeutics has a market cap of A$7.41 Billion. This makes Protagonist Therapeutics the world's 3077th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Protagonist Therapeutics from 2016 to 2026

End of year Market Cap

Year Marketcap Change
2026A$7.41 B-10.48%
2025A$8.28 B121.97%
2024A$3.73 B92.3%
2023A$1.94 B146.11%
2022A$0.78 B-64.97%
2021A$2.25 B99.62%
2020A$1.12 B311.53%
2019A$0.27 B23.72%
2018A$0.22 B-60.43%
2017A$0.55 B9.77%
2016A$0.50 B

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of Protagonist Therapeutics was reported to be:

A$7.47 Billion
by Nasdaq info icon info icon
A$7.47 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
A$1.42 B-80.84%๐Ÿ‡บ๐Ÿ‡ธ USA